NIFTY  8,907.85  0.32%
  SENSEX  28,761.60  0.35%
 CURRENCY  Rs  66.93/$ 70.86/€, 83.36/£
  GOLD  29,292.00  -0.04%
  SILVER  42,835.00  -0.15%
  DAX  11,967.50  1.18%
  FTSE  7,274.83  -0.34%
  CAC  4,888.76  0.41%
  HANG SENG  23,963.60  -0.76%
  NIKKEI  19,381.40  0.68%
  Shanghai Composite  3,253.33  0.23%
  DOW JONES  20,624.10  0.02%
  NASDAQ  5,838.58  0.41%
  S&P 500  2,351.16  0.17%
GOVT OFFICIAL - Govt To Sell 5% Stake In Bharat Electronics On Feb 22 GOVT OFFICIAL - Govt Aims To Raise About Rs 1,600 Cr From BEL Divestment

USFDA Turns Its Gaze On Ranbaxy

Video:

Play this video

January 13: Ranbaxy today said that it has received Form 483 from the U.S. FDA with some observations for its Toansa API plant. Analysts say that if the company is not able to address the concerns of U.S. FDA then an import alert could be issued which would have a significant impact on the company's financials. Bloomberg TV India’s Priya Sheth shares a detailed report on the same.